Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (Lancet, 2022)

(untitled) - Landray, M; Horby, P; Mafham, M; Peto, L; Campbell, M; Pessoa-Amorim, G; Spata, E; Staplin, N; Emberson, J; Haynes, R